THE RAMPx MODEL
Realistic Assessment of Market Potential
RAMPx™ quantifies real-world adoption potential—so you can make smarter clinical, commercial, and investment decisions.
Regulatory approval of life sciences products means little if payers, physicians, and patients don’t adopt and use them. Approval doesn’t guarantee commercial success.
WHO RAMPx SUPPORTS
RAMPx is built for organizations making high-stakes development, investment, and commercialization decisions where real-world adoption ultimately determines success.
PHARMA
BIOTECH
MEDTECH
INVESTORS
BOARDS
WHAT RAMPx DOES
RAMPx is the first FICO-style scoring model that helps life sciences companies understand whether a product is likely to achieve meaningful real-world adoption before critical development and commercialization decisions are finalized.
The framework helps companies:
-
Measure product differentiation versus the current standard of care
-
Evaluate adoption potential across 12 validated real-world drivers
-
Identify adoption barriers, evidence gaps, and areas requiring course correction
-
Determine what to prove, fix, or communicate to improve market readiness
-
Align clinical, commercial, and market access strategy around adoption realities
-
Support smarter investment, portfolio, and commercialization decisions
THE RAMPx PROCESS
RAMPx is designed to pressure-test new product concepts through the eyes of the stakeholders who ultimately determine adoption. The process incorporates payer, physician, patient, and caregiver perspectives to refine positioning, identify barriers, and strengthen real-world market readiness before commercialization decisions are finalized.
01
BEGIN WITH NEW PRODUCT CONCEPT
-
Define the product concept and initial product profile
-
Serves as the foundation for external testing
03
PRESENT CONCEPT TO HCPS
-
Gauge reaction intent
-
Refine concept to strengthen physician motivation to utilize
02
ENGAGE PAYERS / ADMINISTRATORS TO EVALUATE PRODUCT CONCEPT
-
Test payer response to product value and likely
access positioning -
Identify potential access barriers or restrictions
04
LAYER IN PATIENT & CAREGIVERS PERSPECTIVES
-
Present the product as shaped by payers and physicians
-
Understand willingness to seek treatment or ask providers
05
FINALIZE STAKEHOLDER INFORMED PRODUCT CONCEPT
-
Develop a fully pressure-tested product concept aligned across all audiences
WHY RAMPx MATTERS
Most product assessments focus primarily on clinical performance. RAMPx expands the evaluation to include the real-world factors that influence whether physicians prescribe, payers provide access, patients persist, and markets ultimately adopt.
Differentiated
The RAMPx Model’s Comparative Product Performance Analysis Includes:
-
Stakeholder-specific TPP ratings vs. Standard of Care
-
A comparative rating framework
-
Relative factor importance
-
Strength of value proposition scoring
-
Better alignment between clinical outcomes and commercial needs
Prescient
Proven Approach
Tested
WHAT PEOPLE ARE SAYING ABOUT RAMPx
Executives, investors, and healthcare stakeholders are recognizing the importance of understanding adoption before launch. See what they have to say about RAMPx.
 |  |  |  |  |
|---|